Zentalis Pharmaceuticals, Inc. (ZNTL)
1.695
+0.02
(+0.89%)
USD |
NASDAQ |
Nov 13, 16:00
1.695
0.00 (0.00%)
After-Hours: 19:59
Zentalis Pharmaceuticals Net Income (Quarterly) : -28.82M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -28.82M |
| June 30, 2026 | -42.29M |
| March 31, 2026 | -35.35M |
| December 31, 2025 | -35.22M |
| September 30, 2025 | -26.69M |
| June 30, 2025 | -26.87M |
| March 31, 2025 | -48.28M |
| December 31, 2024 | -47.47M |
| September 30, 2024 | -40.16M |
| June 30, 2024 | -88.28M |
| March 31, 2024 | 10.04M |
| December 31, 2023 | -60.94M |
| September 30, 2023 | -55.54M |
| June 30, 2023 | -112.56M |
| March 31, 2023 | -63.26M |
| December 31, 2022 | -54.98M |
| Date | Value |
|---|---|
| September 30, 2022 | -54.50M |
| June 30, 2022 | -68.39M |
| March 31, 2022 | -59.24M |
| December 31, 2021 | -50.10M |
| September 30, 2021 | -10.49M |
| June 30, 2021 | -55.06M |
| March 31, 2021 | -50.44M |
| December 31, 2020 | -40.36M |
| September 30, 2020 | -34.66M |
| June 30, 2020 | -27.29M |
| March 31, 2020 | -16.24M |
| December 31, 2019 | -14.55M |
| September 30, 2019 | -12.57M |
| June 30, 2019 | -10.60M |
| March 31, 2019 | -8.663M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | -35.59M |
| ACADIA Pharmaceuticals, Inc. | 53.52M |
| Alnylam Pharmaceuticals, Inc. | 2.167B |
| Anika Therapeutics, Inc. | -0.311M |
| Savara, Inc. | -42.99M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 28.82M |
| EPS Diluted (Quarterly) | -0.3406 |
| Enterprise Value | -27.11M |
| Earnings Yield | -113.7% |
| Normalized Earnings Yield | -114.45 |